WashPost: A rare deterrent to limitless drug price increases may die under Trump
As drug prices have soared, lawmakers and patient advocates have pushed the federal government to deploy for the first time a powerful deterrent: a legal provision that allows it to suspend a drugmaker’s patent and license someone else to produce the drug. Now, responding to industry alarm over those demands, the Trump administration is proposing …
WashPost: A rare deterrent to limitless drug price increases may die under Trump Read More »